Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission
- PMID: 20130063
- PMCID: PMC2849492
- DOI: 10.1128/JVI.02634-09
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission
Abstract
In the first 6 months of the H1N1 swine-origin influenza virus (S-OIV) pandemic, the vast majority of infections were relatively mild. It has been postulated that mutations in the viral genome could result in more virulent viruses, leading to a more severe pandemic. Mutations E627K and D701N in the PB2 protein have previously been identified as determinants of avian and pandemic influenza virus virulence in mammals. These mutations were absent in S-OIVs detected early in the 2009 pandemic. Here, using reverse genetics, mutations E627K, D701N, and E677G were introduced into the prototype S-OIV A/Netherlands/602/2009, and their effects on virus replication, virulence, and transmission were investigated. Mutations E627K and D701N caused increased reporter gene expression driven by the S-OIV polymerase complex. None of the three mutations affected virus replication in vitro. The mutations had no major impact on virus replication in the respiratory tracts of mice and ferrets or on pathogenesis. All three mutant viruses were transmitted via aerosols or respiratory droplets in ferrets. Thus, the impact of key known virulence markers in PB2 in the context of current S-OIVs was surprisingly small. This study does not exclude the possibility of emergence of S-OIVs with other virulence-associated mutations in the future. We conclude that surveillance studies aimed at detecting S-OIVs with increased virulence or transmission should not rely solely on virulence markers identified in the past but should include detailed characterization of virus phenotypes, guided by genetic signatures of viruses detected in severe cases of disease in humans.
Figures






Similar articles
-
PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells.J Virol. 2010 May;84(9):4395-406. doi: 10.1128/JVI.02642-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181719 Free PMC article.
-
Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus.J Virol. 2012 Sep;86(18):9666-74. doi: 10.1128/JVI.00958-12. Epub 2012 Jun 27. J Virol. 2012. PMID: 22740390 Free PMC article.
-
Substitution of D701N in the PB2 protein could enhance the viral replication and pathogenicity of Eurasian avian-like H1N1 swine influenza viruses.Emerg Microbes Infect. 2018 May 2;7(1):75. doi: 10.1038/s41426-018-0073-6. Emerg Microbes Infect. 2018. PMID: 29717109 Free PMC article.
-
An update on swine-origin influenza virus A/H1N1: a review.Virus Genes. 2009 Dec;39(3):279-92. doi: 10.1007/s11262-009-0404-8. Epub 2009 Oct 7. Virus Genes. 2009. PMID: 19809872 Free PMC article. Review.
-
Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses.Antiviral Res. 2008 Sep;79(3):166-78. doi: 10.1016/j.antiviral.2008.04.006. Epub 2008 May 23. Antiviral Res. 2008. PMID: 18547656 Free PMC article. Review.
Cited by
-
Evolution, safety, and highly pathogenic influenza viruses.Science. 2012 Jun 22;336(6088):1529-31. doi: 10.1126/science.1223204. Science. 2012. PMID: 22723411 Free PMC article.
-
Continuous evolution of influenza A viruses of swine from 2013 to 2015 in Guangdong, China.PLoS One. 2019 Jul 19;14(7):e0217607. doi: 10.1371/journal.pone.0217607. eCollection 2019. PLoS One. 2019. PMID: 31323023 Free PMC article.
-
Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.mSphere. 2018 Apr 4;3(2):e00110-18. doi: 10.1128/mSphere.00110-18. Print 2018 Apr 25. mSphere. 2018. PMID: 29624498 Free PMC article.
-
Nucleotide sequence as key determinant driving insertions at influenza A virus hemagglutinin cleavage sites.Npj Viruses. 2024 May 13;2(1):17. doi: 10.1038/s44298-024-00029-1. Npj Viruses. 2024. PMID: 40295814 Free PMC article.
-
Evaluation of the human adaptation of influenza A/H7N9 virus in PB2 protein using human and swine respiratory tract explant cultures.Sci Rep. 2016 Oct 14;6:35401. doi: 10.1038/srep35401. Sci Rep. 2016. PMID: 27739468 Free PMC article.
References
-
- Dawood, F. S., S. Jain, L. Finelli, M. W. Shaw, S. Lindstrom, R. J. Garten, L. V. Gubareva, X. Xu, C. B. Bridges, and T. M. Uyeki. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615. - PubMed
-
- de Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang, N. V. Chau, T. H. Khanh, V. C. Dong, P. T. Qui, B. V. Cam, Q. H. Do, Y. Guan, J. S. Peiris, N. T. Chinh, T. T. Hien, and J. Farrar. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207. - PMC - PubMed
-
- de Wit, E., V. J. Munster, D. van Riel, W. E. P. Beyer, G. F. Rimmelzwaan, T. Kuiken, A. D. M. E. Osterhaus, and R. A. M. Fouchier. 2010. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J. Virol. 84:1597-1606. - PMC - PubMed
-
- de Wit, E., M. I. Spronken, T. M. Bestebroer, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2004. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res. 103:155-161. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous